Page last updated: 2024-08-21

durapatite and ibandronic acid

durapatite has been researched along with ibandronic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauss, F; Eberhardt, C; Kurth, AH; Müller, S; Schwarz, M; Steinacker, M1
Bauss, F; Eberhardt, C; Habermann, B; Kurth, AH; Müller, S; Schwarz, M1
Bao, C; Gao, Y; Hu, J; Liu, X; Zou, S1
Henry, C; Jahnke, W1
Chaurasia, S; Di Stilo, A; Ferracini, R; Fruttero, R; Gasco, A; Gorassini, E; Lazzarato, L; Lolli, ML; Oliaro-Bosso, S; Rolando, B; Tosco, P1
Shiraishi, A1

Reviews

1 review(s) available for durapatite and ibandronic acid

ArticleYear
[Pharmacological profile and clinical evidence in patients with primary osteoporosis treated with intravenous ibandronate].
    Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2014, Volume: 143, Issue:6

    Topics: Animals; Bone and Bones; Bone Density; Bone Density Conservation Agents; Cholecalciferol; Diphosphonates; Disease Models, Animal; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Durapatite; Haplorhini; Humans; Ibandronic Acid; Infusions, Intravenous; Osteoporosis; Randomized Controlled Trials as Topic; Rats; Spinal Fractures

2014

Other Studies

5 other study(ies) available for durapatite and ibandronic acid

ArticleYear
The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.
    Bone, 2005, Volume: 37, Issue:2

    Topics: Animals; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Durapatite; Female; Femur; Ibandronic Acid; Osseointegration; Osteoporosis; Ovariectomy; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Titanium

2005
The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model.
    Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association, 2007, Volume: 12, Issue:1

    Topics: Animals; Bone Density Conservation Agents; Coated Materials, Biocompatible; Diphosphonates; Disease Models, Animal; Durapatite; Female; Femoral Fractures; Ibandronic Acid; Injections, Subcutaneous; Osseointegration; Rats; Rats, Sprague-Dawley; Treatment Outcome

2007
The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats.
    Biomaterials, 2009, Volume: 30, Issue:9

    Topics: Absorptiometry, Photon; Animals; Biomechanical Phenomena; Bone Density; Coated Materials, Biocompatible; Diphosphonates; Durapatite; Female; Ibandronic Acid; Imidazoles; Implants, Experimental; Microscopy, Electron, Scanning; Ovariectomy; Pamidronate; Rats; Rats, Sprague-Dawley; Surface Properties; Tibia; Titanium; X-Ray Microtomography; Zoledronic Acid

2009
An in vitro assay to measure targeted drug delivery to bone mineral.
    ChemMedChem, 2010, May-03, Volume: 5, Issue:5

    Topics: Alendronate; Anabolic Agents; Bone and Bones; Bone Density Conservation Agents; Diphosphonates; Drug Delivery Systems; Durapatite; Etidronic Acid; Humans; Ibandronic Acid; Imidazoles; Nuclear Magnetic Resonance, Biomolecular; Pamidronate; Risedronic Acid; Zoledronic Acid

2010
Synthesis and preliminary pharmacological characterisation of a new class of nitrogen-containing bisphosphonates (N-BPs).
    Bioorganic & medicinal chemistry, 2010, Apr-01, Volume: 18, Issue:7

    Topics: Animals; Aorta, Thoracic; Bone and Bones; Bone Density Conservation Agents; Cells, Cultured; Chromatography, Affinity; Diphosphonates; Durapatite; Farnesyl-Diphosphate Farnesyltransferase; Humans; Ibandronic Acid; In Vitro Techniques; Macrophages; Magnetic Resonance Spectroscopy; Male; Mice; Microsomes, Liver; Models, Molecular; Muscle, Smooth, Vascular; Nitric Oxide Donors; Nitrogen; Osteogenesis; Rats; Rats, Wistar; Vasodilator Agents

2010